The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Lance C. Pagliaro

Unit 1374

The University of Texas MD Anderson Cancer Center

1155 Pressler St

Houston

[email]@mdanderson.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Unit 1374, The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston. 2011
  • Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. 2000 - 2010

References

  1. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment. Tzelepi, V., Efstathiou, E., Wen, S., Troncoso, P., Karlou, M., Pettaway, C.A., Pisters, L.L., Hoang, A., Logothetis, C.J., Pagliaro, L.C. J. Clin. Oncol. (2011) [Pubmed]
  2. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. Pagliaro, L.C., Williams, D.L., Daliani, D., Williams, M.B., Osai, W., Kincaid, M., Wen, S., Thall, P.F., Pettaway, C.A. J. Clin. Oncol. (2010) [Pubmed]
  3. Multimodality therapy in penile cancer: when and which treatments?. Pagliaro, L.C., Crook, J. World. J. Urol (2009) [Pubmed]
  4. Review of metastatic bladder cancer. Pagliaro, L.C., Sharma, P. Minerva. Urol. Nefrol (2006) [Pubmed]
  5. Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma. Pagliaro, L.C., Perez, C.A., Tu, S.M., Daliani, D.D. Urol. Oncol. (2006) [Pubmed]
  6. A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases. Pagliaro, L.C., Delpassand, E.S., Williams, D., Millikan, R.E., Tu, S.M., Logothetis, C.J. Cancer (2003) [Pubmed]
  7. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy. Pagliaro, L.C., Keyhani, A., Williams, D., Woods, D., Liu, B., Perrotte, P., Slaton, J.W., Merritt, J.A., Grossman, H.B., Dinney, C.P. J. Clin. Oncol. (2003) [Pubmed]
  8. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin. Pagliaro, L.C., Keyhani, A., Liu, B., Perrotte, P., Wilson, D., Dinney, C.P. Urol. Oncol. (2003) [Pubmed]
  9. Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma. Pagliaro, L.C., Millikan, R.E., Tu, S.M., Williams, D., Daliani, D., Papandreou, C.N., Logothetis, C.J. J. Clin. Oncol. (2002) [Pubmed]
  10. Gene therapy for bladder cancer. Pagliaro, L.C. World. J. Urol (2000) [Pubmed]
 
WikiGenes - Universities